Editors' Comments

This is the authors' abstract. We don't add key points for this paper.

This patient presents a history of chronic uveitis, previous synechia, and macular edema, in addition to a high degree of hyperopia. All experts stressed the importance of properly managing the inflammatory process and assessing the integrity of the posterior capsule. Although it is recommended that the CME treatment be combined with a retinal specialist, all the anterior segment surgeons agree on either using an oral or systemic treatment steroid or dexamethasone implantation (if the posterior capsule is intact) and even PPV with intravitreal injection as options. If the capsular bag were intact, the implant in the sulcus would be an option after adequate analysis and removal of synechiae. If not intact (which was the case here), there would be scleral fixation options with glue or other techniques available. New fixation techniques, as the glue IOL described by Agarwal et al., have made these options easier, safer, and more predictable. They should, therefore, always be considered in cases of this nature. Another option after adequate control of the inflammatory process, recently published as safe and effective, would be a phakic iris-claw IOL implantation. In this case, a phakic IOL was implanted on the patient's left eye (Figure 2), in which she had greater intolerance to the contact lens. After 3 years of follow-up, there was an improvement in vision and no sign of recurrent inflammatory reaction. Evaluated by a specialist in uveitis, the patient obtained adequate inflammatory control before surgery. Endothelial cells were monitored preoperatively and postoperatively.